These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 10280670)

  • 1. Patient variations in alcohol treatment utilization.
    Hoffman NG; Harrison PA
    Bus Health; 1987 Mar; 4(5):16-8. PubMed ID: 10280670
    [No Abstract]   [Full Text] [Related]  

  • 2. Continued changing patterns in coverage and utilization of mental health, alcohol, and substance abuse within HMOs.
    Levin BL
    GHAA J; 1987-1988 Winter; 8(2):17-29. PubMed ID: 10318058
    [No Abstract]   [Full Text] [Related]  

  • 3. The referral system: deciders and influencers in the alcohol and chemical dependency treatment system.
    Kline TA; Ingram JI; Self DR
    J Mark Ment Health; 1987-1988 Summer; 1(2):81-94. PubMed ID: 10317980
    [No Abstract]   [Full Text] [Related]  

  • 4. Alcoholism treatment episodes validly defined using mental health care utilization records.
    Wall MM; Stromberg KD; Pothoff S; Kane RL
    J Clin Epidemiol; 2004 Apr; 57(4):373-80. PubMed ID: 15135838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization and cost of mental health, substance abuse, and medical services among at-risk drinkers.
    Nietert PJ; French MT; Kirchner JE; Booth BM
    Med Care Res Rev; 2007 Aug; 64(4):431-48. PubMed ID: 17684111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and utilization of alcoholism treatment under health insurance. A review of three studies.
    Ryan K
    Alcohol Health Res World; 1984-1985 Winter; 9(2):45-52, 72. PubMed ID: 10270903
    [No Abstract]   [Full Text] [Related]  

  • 7. Utilization of mental health services and risk of 12-month problematic alcohol use.
    Encrenaz G; Kovess-Masféty V; Sapinho D; Chee CC; Messiah A
    Am J Health Behav; 2007; 31(4):392-401. PubMed ID: 17511574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental health service utilization in the United States. The role of personality factors.
    Goodwin RD; Hoven CW; Lyons JS; Stein MB
    Soc Psychiatry Psychiatr Epidemiol; 2002 Dec; 37(12):561-6. PubMed ID: 12545232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is the European Addiction Severity Index a useful tool in the diagnostic routines of alcohol dependence?].
    Schmidt P; Küfner H; Hasemann S; Löhnert B; Kolb W; Zemlin U; Soyka M
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):541-8. PubMed ID: 17380465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic variation in alcohol, drug abuse, and mental health services utilization: what is the role of physician practice patterns?
    Hudson N
    Find Brief; 2007 Nov; 10(7):1-2. PubMed ID: 18027456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Data collection methods and results in user surveys in mental health care].
    Bjertnaes ØA; Garratt A; Johannessen JO
    Tidsskr Nor Laegeforen; 2006 May; 126(11):1481-3. PubMed ID: 16732343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living arrangements, sense of well-being, and use of mental health services by U.S. adults: implications for health policy.
    Davis MA; Lee ES; Neuhaus JM
    J Health Hum Resour Adm; 1987; 9(3):319-39. PubMed ID: 10283170
    [No Abstract]   [Full Text] [Related]  

  • 13. Purchasers address escalating psychiatric and substance abuse utilization.
    Lee FC
    Empl Benefits J; 1987 Mar; 12(1):9-13. PubMed ID: 10317854
    [No Abstract]   [Full Text] [Related]  

  • 14. Organization and delivery of alcohol and drug abuse treatment in HMOs.
    Shadle M; Christianson JB
    GHAA J; 1989 May; 10(1):9-27. PubMed ID: 10318249
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypomania with and without Dysphoria: comparison of comorbidity and clinical characteristics of respondents from a national community sample.
    Agosti V; Stewart JW
    J Affect Disord; 2008 May; 108(1-2):177-82. PubMed ID: 17963847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient mental health utilization among commercially insured individuals: in- and out-of-network care.
    Stein BD; Meili R; Tanielian TL; Klein DJ
    Med Care; 2007 Feb; 45(2):183-6. PubMed ID: 17224782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Private insurance and the utilization of chemical dependency treatment.
    Schmidt LA; Weisner CM
    J Subst Abuse Treat; 2005 Jan; 28(1):67-76. PubMed ID: 15723734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term recovery from alcohol abuse or dependence: any evidence of a relationship with treatment use in a general population sample?
    Cunningham JA
    Alcohol Alcohol; 2005; 40(5):419-21. PubMed ID: 15939710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demand for psychiatric services: a clinical episode model for specifying "the product".
    Goldman HH; Scheffler RM; Cheadle A
    Adv Health Econ Health Serv Res; 1987; 8():255-73. PubMed ID: 10312959
    [No Abstract]   [Full Text] [Related]  

  • 20. State mandates for mental health, alcohol, and substance abuse benefits: implications for HMOs.
    Levin BL
    GHAA J; 1988; 9(2):48-69. PubMed ID: 10318180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.